Cathelicidin-1, CATH-1, Fowlicidin-1

General Information


DRACP ID  DRACP00384

Peptide Name   Cathelicidin-1, CATH-1, Fowlicidin-1

Sequence  RVKRVWPLVIRTVIAGYNLYRAIKKK

Sequence Length  26

UniProt ID  Q6QLQ5  C4PFJ7 

PubChem CID  Not available

Origin  Gallus gallus

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse macrophage leukemia cell Leukemia 60% cell death=20 μM; 90% cell death=40 μM MTT assay 48 h 1

Hemolytic Activity  Human erythrocytes: 15.6% Hemolysis=4 µM; 23.1% Hemolysis=8 µM; 33.1% Hemolysis=16 µM; 43.6% Hemolysis=32 µM; 74.3% Hemolysis=64 µM; 87.4% Hemolysis=128 µM; Sheep erythrocytes: 10% Hemolysis=38 µM

Normal (non-cancerous) Cytotoxicity  Madin-Darby canine kidney cells: 50% Cell death=15 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  2AMN  

Predicted Structure  DRACP00384

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C148H250N44O31

Absent amino acids  CDEFHMQS

Common amino acids  KRV

Mass  358799

Pl  12.13

Basic residues  8

Acidic residues  0

Hydrophobic residues  12

Net charge  8

Boman Index  -4372

Hydrophobicity  -6.92

Aliphatic Index  127.31

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  8480

Absorbance 280nm  339.2

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Improving Cell Selectivity of Fowlicidin-1 by Swapping Residues between Pro-7 and Tyr-20

Doi 10.1002/bkcs.11738

Year  2019

Literature 2

Pubmed ID 16817888

Title  Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken

Doi 10.1111/j.1742-4658.2006.05261.x

Year  2006

Literature 3

Pubmed ID 31473417

Title  The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities

Doi 10.1016/j.ejmech.2019.111623

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_11

DRACP is developed by Dr.Zheng's team.